Fecal Microbiota Transplantation Combined With QL1706 Plus Bevacizumab for Advanced HCC

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a prospective, single-center, single-arm Phase II pilot study designed to evaluate the efficacy and safety of FMT in combination with QL1706 and Bevacizumab as first-line treatment for advanced Hepatocellular carcinoma.
Epistemonikos ID: d88812d3a5328ffb26764ae0ad2982311d6c3d81
First added on: Sep 30, 2026